Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 1576 AL 1590

Variants in the proteasome regulator PSMF1 cause a phenotypic spectrum from early-onset Parkinson's disease to perinatal lethality and disrupt mitochondrial function

Magrinelli F, Tesson C, Angelova PR, Rodriguez JA, Scardamaglia A, O'Callaghan B, Lowe SA, Salazar-Villacorta A, Chung BH, Jaconelli M, Vona B, Esteras N, Mammana A, Shimazu J, Kwong AK, Courtin T, Alavi S, Maroofian R, Nirujogi R, Severino M, Monfrini E, Rocca C, Lewis PA, Efthymiou S, Buchert R, Sofan L, Lis P, Pinon C, Breedveld GJ, Chui MM, Murphy D, Pitz V, Makarious MB, Baiardi S, Volin M, Cassar M, Hassan BA, Iftikhar S, Bauer P, Tinazzi M, Svetel M, Samanci B, Hanağası HA, Bilgiç B, Cavallieri F, Santangelo M, Obeso JA, Kurtis MM, Cogan G, Kiziltan G, Gül-Demirkale T, Tireli H, Yüksel GA, Yalçın-Cakmakli G, Elibol B, Barišić N, Ng EW, Fan SS, Hershkovitz T, Weiss K, Alvi JR, Sultan T, Alkhawaja IA, Froukh T, Alrukban HAE, Fauth C, Schatz UA, Zöggeler T, Zech M, Stals K, Varghese V, Gandhi S, Blauwendraat C, Hardy JA, Di Fonzo A, Bonifati V, Haack TB, Bertoli-Avella AM, Lesage S, Başak AN, Steinfeld R, Parchi P, Jepson JEC, Alessi DR; PSMF1 Study Group; Brice A, Steller H, Abramov AY, Bhatia KP, Houlden H.

medRxiv [Preprint]. 2025 Jul 21:2024.06.19.24308302. doi: 10.1101/2024.06.19.24308302.

Predicting Cerebrospinal Fluid Alpha-Synuclein Seed Amplification Assay Status from Demographics and Clinical Data

Venuto CS, Herbst K, Chahine LM, Kieburtz K.

medRxiv [Preprint]. 2025 Mar 7:2024.08.07.24311578. doi: 10.1101/2024.08.07.24311578.

Increased vowel contrast and intelligibility in connected speech induced by sensorimotor adaptation

Beach SD, Johnson SA, Parrell B, Niziolek CA.

bioRxiv [Preprint]. 2025 Feb 13:2024.08.04.606537. doi: 10.1101/2024.08.04.606537.

Heads-Up! A Caregiver's Perspective on Lewy Body Dementia

Warrington FS.

Am J Med. 2025 Jan;138(1):21-24. doi: 10.1016/j.amjmed.2024.08.001. Epub 2024 Aug 14.

Daidzein's potential in halting neurodegeneration: unveiling mechanistic insights

Singh L.

Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):243-259. doi: 10.1007/s00210-024-03356-5. Epub 2024 Aug 19.

Nasal microbiome dynamics: decoding the intricate nexus in the progression of respiratory and neurological diseases

Maheshwari K, Gupta R, Sharma R, Kaur A, Vashist A, Aggarwal G.

Crit Rev Microbiol. 2025 Aug;51(4):581-596. doi: 10.1080/1040841X.2024.2391488. Epub 2024 Aug 19.

MicroRNAs Modulating Neuroinflammation in Parkinson's disease

Saadh MJ, Muhammad FA, Singh A, Mustafa MA, Al Zuhairi RAH, Ghildiyal P, Hashim G, Alsaikhan F, Khalilollah S, Akhavan-Sigari R.

Inflammation. 2025 Jun;48(3):1042-1062. doi: 10.1007/s10753-024-02125-z. Epub 2024 Aug 20.

The P300 component of the auditory event-related potential in adult psychiatric and neurologic disorders: a narrative review of clinical and experimental evidence

Raggi A, Serretti A, Ferri R.

Int Clin Psychopharmacol. 2025 Sep 1;40(5):259-274. doi: 10.1097/YIC.0000000000000566. Epub 2024 Aug 21.

The impact of combined aerobic and resistance exercise on the prognosis of early Parkinson's disease patients

Chen Y, Chen Y.

Technol Health Care. 2025;33(1):205-214. doi: 10.3233/THC-240821.

The Role of Mitochondrial Pyruvate Carrier in Neurological Disorders

Liu Y, Yu X, Jiang W.

Mol Neurobiol. 2025 Mar;62(3):2846-2856. doi: 10.1007/s12035-024-04435-7. Epub 2024 Aug 23.

Clinical characteristics and phenoconversion in isolated REM sleep behavior disorder: a prospective single-center study in Korea, compared with Montreal cohort

Byun JI, Sunwoo JS, Shin YW, Shin JW, Kim TJ, Jun JS, Shin JH, Kim HJ, Montplaisir J, Gagnon JF, Pelletier A, Delva A, Postuma RB, Jung KY.

J Clin Sleep Med. 2025 Jan 1;21(1):81-88. doi: 10.5664/jcsm.11318.

Experimental and Computational Methods for Allelic Imbalance Analysis from Single-Nucleus RNA-seq Data

Simmons SK, Adiconis X, Haywood N, Parker J, Lin Z, Liao Z, Tuncali I, Al'Khafaji AM, Shin A, Jagadeesh K, Gosik K, Gatzen M, Smith JT, El Kodsi DN, Kuras Y, Baecher-Allan C, Serrano GE, Beach TG, Garimella K, Rozenblatt-Rosen O, Regev A, Dong X, Scherzer CR, Levin JZ.

bioRxiv [Preprint]. 2025 Jan 15:2024.08.13.607784. doi: 10.1101/2024.08.13.607784.

Heavy metals exposure and Alzheimer's disease: Underlying mechanisms and advancing therapeutic approaches

Althobaiti NA.

Behav Brain Res. 2025 Jan 5;476:115212. doi: 10.1016/j.bbr.2024.115212. Epub 2024 Aug 24.

A Meta-Analysis of Medication Reduction and Motor Outcomes After Awake Versus Asleep Deep Brain Stimulation for Parkinson Disease

Li L, Rae AI, Burchiel KJ.

Neurosurgery. 2025 Mar 1;96(3):481-493. doi: 10.1227/neu.0000000000003138. Epub 2024 Aug 28.

Simultaneous Increase of Mean Susceptibility and Mean Kurtosis in the Substantia Nigra as an MRI Neuroimaging Biomarker for Early-Stage Parkinson's Disease: A Systematic Review and Meta-Analysis

Mohammadi S, Ghaderi S, Mohammadi H, Fatehi F.

J Magn Reson Imaging. 2025 Apr;61(4):1797-1809. doi: 10.1002/jmri.29569. Epub 2024 Aug 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias